SVB Leerink Begins Coverage on Neurogene (NASDAQ:NGNE)
SVB Leerink initiated coverage on shares of Neurogene (NASDAQ:NGNE – Free Report) in a research report report published on Monday, MarketBeat reports. The firm issued an outperform rating and a $46.00 target price on the stock. Several other equities analysts have also commented on the stock. Stifel Nicolaus initiated coverage on shares of Neurogene in […]
More Stories
Amar Doman Acquires 60,000 Shares of Doman Building Materials Group Ltd. (TSE:DBM) Stock
Doman Building Materials Group Ltd. (TSE:DBM – Get Free Report) Director Amar Doman acquired 60,000 shares of the stock in...
Rithm Capital Corp. (NYSE:RITM) Shares Sold by Teacher Retirement System of Texas
Teacher Retirement System of Texas decreased its holdings in Rithm Capital Corp. (NYSE:RITM – Free Report) by 22.5% in the...
Insider Buying: TFI International Inc. (TSE:TFII) Director Acquires C$399,279.52 in Stock
TFI International Inc. (TSE:TFII – Get Free Report) Director Sébastien Martel purchased 2,110 shares of the firm’s stock in a...
Atkore Inc. (NYSE:ATKR) Stake Decreased by Teacher Retirement System of Texas
Teacher Retirement System of Texas trimmed its holdings in Atkore Inc. (NYSE:ATKR – Free Report) by 58.2% in the fourth...
David L. Duvall Sells 17,513 Shares of Core Molding Technologies, Inc. (NYSEAMERICAN:CMT) Stock
Core Molding Technologies, Inc. (NYSEAMERICAN:CMT – Get Free Report) CEO David L. Duvall sold 17,513 shares of Core Molding Technologies...
Voyager Therapeutics (NASDAQ:VYGR) Rating Reiterated by Oppenheimer
Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Oppenheimer in a...